Mexico Veterinary Healthcare Market - Growth, Trends, Covid-19 Impact, And Forecasts (2023 - 2028)

Mexico Veterinary Healthcare Market - Growth, Trends, Covid-19 Impact, And Forecasts (2023 - 2028)

The Mexican veterinary healthcare market is projected to register a CAGR of nearly 8% during the forecast period.

The COVID-19 pandemic has impacted the animal healthcare market by increasing the costs of animal testing and veterinary care. Supply chain disruptions and shortages of veterinary medicines were observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine for the treatment of COVID-19. For instance, according to an article published in February 2021, the demand for veterinary services and visits to pet clinics reduced in the country during the COVID-19 pandemic, thus impacting the growth of the veterinary healthcare market. However, with pet clinic services resuming and the relaxation of COVID-19 restrictions, the Mexican veterinary healthcare market is expected to grow over the forecast period.

The increasing productivity at the risk of emerging zoonosis and advancements in technology leading to innovations in animal healthcare are boosting the market's growth. For instance, according to an article published in July 2021, 600 confirmed cases of Rickettsia infections were reported in Mexico, % of which occurred in Yucatan in 2020. This factor increased the demand for proper vaccinations in the country, which is further anticipated to increase the need for proper veterinary healthcare system and contribute to the market's growth over the forecast period.

As per the data published by the Global Health Security Index, 2021, Mexico, the Ministry of Health published its National Health Promotion Days plan, which includes the Guidelines for Disease Prevention and Control Programs: Zoonosis. The recommendations reflect on the idea of One Health and notably address campaigns to stop and prevent the spread of brucellosis, rabies, and porcine tapeworm. Such initiatives are projected to create opportunities for companion healthcare products, thus driving the veterinary healthcare market over the forecast period.

As per the same source, the guidelines also mentioned the 2019-2024 Specific Action Program (PAE) for Zoonosis Prevention and Control in Public Health. Such activities are expected to increase awareness regarding zoonotic diseases and their spread among the population, as well as increase the demand for specific vaccination for companion animals. Such developments may fuel the market's growth over the forecast period.

Technological advancements in the animal healthcare sector have been increasing over time, leading to the development of smart wearable devices, livestock monitoring systems, electronic recording systems, which are expected to boost the market's growth over the forecast period. For instance, as per an article published in March 2021, the use of AI in animal health has made it feasible to tackle extremely complicated problems, such as those found in quantitative and predictive epidemiology, animal precision-based medicine, or the investigation of host-pathogen interactions.

As per the same source, other AI approaches such as multi-agent models, which take a more mechanical approach, have been applied in an explicit spatial context for the transmission of vector-borne pathogens, which have proven to be sufficiently adaptable for several animal studies. Thus, the rising utilization of advanced technologies to study different parameters in animals are expected to boost the growth of the veterinary healthcare market over the forecast period.

However, the increasing cost of animal healthcare and veterinary testing, scarcity of arable land and water, and the use of counterfeit medicines are likely to hamper the market's growth over the forecast period.

The vaccines segment is expected to witness significant growth in the companion animal healthcare market over the forecast period due to the rising prevalence of zoonotic diseases and the increasing product launches.

Vaccines include viruses, bacteria, or other disease-causing organisms that have been killed or altered to prevent any disease, thus, boosting immunity. New advanced vaccines have been manufactured containing genetically engineered components derived from those disease agents.

The increasing number of zoonotic disease cases in the country is the key factor driving the market's growth. For instance, in September 2022, the New Mexico DOH reported the first human patient diagnosed with West Nile virus infection in New Mexico. About 33 people were diagnosed with West Nile virus in New Mexico in 2021. Such new cases in the country are expected to increase the demand for and the adoption of animal healthcare to prevent the spread of zoonotic disease. This factor is anticipated to fuel the market's growth over the forecast period.

The rising government initiatives in spreading awareness regarding veterinary health and launching prevention programs in the country are also expected to fuel the market's growth over the forecast period. For instance, as per the WHO data published in January 2022, Mexico became the first country in the world to receive validation from the WHO for eliminating dog-transmitted rabies as a public health problem through a vaccination program conducted by the Mexican government.

The increasing product launches are also contributing to the market's growth. For instance, in April 2021, Vetanco partnerd launched Circo/MycoGard vaccine in Argentina and Latin America, including Mexico.

Therefore, such factors are expected to boost the growth of the segment in the market during the forecast period.

The Mexican veterinary healthcare market is primarily dominated by a few players. However, currently, some of the other companies are focusing on penetrating the market and are expected to hold a substantial market share. Major players are Zoetis Animal Healthcare, Merck Animal Health, Bayer Animal Health, Ceva Animal Health Inc., Virbac Corporation, Boehringer Ingelheim, and Elanco Animal Health.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support